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ABSTRACT
Degeneration of nociceptive afferent axons and terminals in the heart is
associated with painless sudden cardiac death. However, innervation, distribution
and morphological structures of sympathetic cardiac nociceptive afferent axons
and terminals have not yet been fully characterized. The aim of the present study
is to characterize the density, arrangement, and structural features of
differentiated sympathetic afferent axons and terminals in whole-mount FVB
mouse atria. FVB mice (3-6 months old) were perfused and the tissues were
fixed. The right and left atria were processed with immunohistochemistry.
Calcitonin gene-related peptide (CGRP) and substance P (SP) are two
neuropeptides which have been widely used to label sympathetic nociceptive
afferent axons in many tissues. CGRP (rabbit anti-CGRP) and SP (Goat anti-SP)
primary antibodies were applied, followed by Alexa Fluor 594 and 660
conjugated secondary antibodies. Whole-mount preparations of right and left
atria were examined using a laser scanning confocal microscope. We found that
1) CGRP immunoreactive (IR) axon bundles innervated the right and left atria
including the auricle and entrance area of the superior vena cava, the inferior
vena cava, left precaval vein and pulmonary veins. Large axon bundles entered
the area from the major veins and bifurcated into smaller axon bundles and
single axon fibers to form terminal end-nets and free endings in the epicardium at
each region with a similar pattern. In the atrial muscle layer, varicose CGRP-IR
axons had close contacts with muscle fibers. In addition, CGRP-IR axons
iii

terminated in the intrinsic cardiac ganglia (ICGs) with varicosities surrounding
individual ganglionic principle neurons (PNs). In the aortic arch, the CGRP-IR
fibers exhibited similar terminal structures to those seen in the atria. 2) SP-IR
axons also projected to the right and left atria and aorta. Similar to CGRP-IR
axons, these SP-IR axons also formed end-nets and free endings in these areas.
In cardiac ganglia, SP-IR axons formed varicose endings around many individual
PNs. However, a salient difference was found: There appeared to be fewer SPIR axons and terminals than CGRP-IR axons and terminals in the atria. 3) None
of the cardiac PNs in ICG were CGRP-IR or SP-IR. 4) Many SP-IR axon
terminals around PNs within ICGs and atrial muscles were found to have
colocalized expression of CGRP-IR. Collectively, our data for the first time
documented the distribution patterns and morphology of sympathetic afferent
axons and terminals in each region of the atria in the mouse model. This will
provide a foundation for future analysis of the pathological changes of
sympathetic afferent nerves in the atria in different disease models (e.g.,
diabetes, sleep apnea, and aging). This study was supported by NIH R01 HL79636.

iv

ACKNOWLEDGMENTS
I would like to express my sincere thanks to my committee: Dr. Ella BossyWetzel, Dr. Sic L. Chan and Dr. Mohtashem Samsam for their constructive
suggestions and insightful comments on my thesis.

My heartfelt thanks also go to my lab members: Lihua Li, for teaching me
the delicate microsurgical and tissue dissecting skills; Scott Harden for his
talented confocal imaging skills as well as patiently helping me improve my
English; Jeffery Hatcher for attentively editing my thesis; Drs. Xueguo Zhang,
Binbin Yan, and He Gu for thoroughly walking me through the
electrophysiological techniques; Drs. He Gu and Binbin Yan for their warm,
generous support and instructing me in general lab skills.

I am especially grateful to my advisor, Dr. Zixi (Jack) Cheng for providing
me with the highest quality research training. He guided me step by step
throughout my graduate student career: scholastics, critical analysis of the
literature, mentoring me on how to be a more careful and conscientious
researcher, and all his helpful suggestions and criticisms for my Thesis. In
addition, he spent a lot of time teaching me English as well as presentation skills,
which is of great importance to me for building my self-confidence. Finally, he set
a great example of finding the balance between work and everyday life. I enjoyed
every minute with him and have learned many things that will benefit me
throughout my whole life.
v

My deepest thanks also go to my parents and my aunt who have
unselfishly supported and encouraged me in my academic career, and whose
values and love have guided me while I was far from home.

Last but not least, I give thanks to my wife who has been my greatest
inspiration and closest friend. She has lovingly supported me through many
difficult times. Without her, it would not have been possible for me to accomplish
my thesis.

vi

TABLE OF CONTENTS
LIST OF FIGURES........................................................................................ix
LIST OF ACRONYMS / ABBREVIATIONS .................................................xi
INTRODUCTION .......................................................................................... 1
MATERIALS AND METHODS..................................................................... 4
Animals ..................................................................................................... 4
Tissue Preparation .................................................................................... 4
Immunohistochemistry .............................................................................5
Data collection and analysis ..................................................................... 6
RESULTS ...................................................................................................... 8
Innervation, distribution and morphology of CGRP-IR axon and
terminals in whole-mount atria ........................................................................... 8
CGRP-IR innervation of the whole-mount aortic arch ............................ 9
Innervation, distribution and morphology of SP-IR axon and terminals
in whole-mount atria ........................................................................................... 9
CGRP-IR and SP-IR innervation: dual labeling in the atria ...................10
DISCUSSION ............................................................................................... 11
Origin of CGRP-IR and SP-IR axons. ...................................................... 11
Innervation, distribution and morphology of CGRP-IR and SP-IR axons
and terminals in the whole-mount atria of mice. ............................................... 12
Functional implications ........................................................................... 13
Technical considerations. ........................................................................ 15
PERSPECTIVE............................................................................................. 17
vii

APPENDIX: TABLES AND FIGURES ........................................................ 18
REFERENCES ............................................................................................ 42

viii

LIST OF FIGURES
Figure 1. Autonomic nervus system research progress review .................. 20
Figure 2 Tissue preparation. ....................................................................... 21
Figure.3 A montage of all-in-focus maximum confocal projections showing
CGRP-IR innervation and distribution of the right atrium of a FVB mouse. ...... 22
Figure 4. A montage of all-in-focus maximum confocal projections
showing CGRP-IR innervation and distribution of the left atrium of a FVB mouse.
................................................................................................................................ 25
Figure 5. Two schematic drawings showing innervation and distribution
of CGRP-IR axons in the whole-mount right and left atria in the FVB mouse as
shown in Figures 3 and 4. ...................................................................................... 26
Figure 6. CGRP-IR axons and terminals in the atria. ................................ 28
Figure 7. CGRP-IR axons in epicardium and myocardium. ...................... 29
Figure 8. CGRP-IR axons in the entrance area of the major veins. ........... 30
Figure 9. CGRP-IR axons innervated intrinsic cardiac ganglia (ICGs) in the
left atrium of a representative mouse. .................................................................. 32
Figure 10. CGRP-IR axon innervated the intrinsic cardiac ganglia (ICGs) of
the right atrium. ..................................................................................................... 33
Figure 11. CGRP-IR axons in the aortic arch.............................................. 35
Figure 12 SP-IR axons innervation in atria. ................................................37
Figure 13 Colocalization of SP-IR axons with CGRP-IR axons in an axon
bundle. ................................................................................................................... 38
Figure 14. CGRP-IR and SP-IR Innervation of the ICGs: dual labeling. ... 39
ix

Figure 15. CGRP-IR and SP-IR axons and terminals in the small intestine
of a FVB mouse. ..................................................................................................... 40
Figure 16. Summary diagram of CGRP and SP innervation and functions in
the atria ................................................................................................................... 41

x

LIST OF ACRONYMS / ABBREVIATIONS
CGRP

Calcitonin Gene Related Peptide

SP

Substance P

IR

Immunoreactivity

ICG

Intrinsic Cardiac Ganglion

ICGN

Intrinsic Cardiac Ganglionic Neurons

PN

Principal Neuron

IHC

Immunohistochemical / Immunohistochemistry

PBS

Phosphate-Buffered Saline

ZF

Zamboni’s Fixative

CM

Circular Muscle

MG

Myenteric Ganglia

ACh

Acetylcholine

xi

INTRODUCTION
Silent cardiac ischemia is a deadly serious condition that frequently occurs in the
patients with cardiac failure, with advanced age, and after long-term diabetes (Faerman
et al., 1977; Gutterman, 2009). Although the exact underlying mechanism for this
devastating event is not clear, it is apparently related to cardiac nociceptive nerve
degeneration (Faerman et al., 1977, Ambepityia et al., 1990; Langer et al, 1991).
Therefore, it is critically important to characterize the remodeling of sympathetic
nociceptive nerves in cardiac tissue. However, innervation, distribution and morphology
of sympathetic nociceptive fibers and terminals have not yet been completely
elucidated, which has seriously impeded the progress of focused investigation on
diseased-induced pathological changes of sympathetic cardiac nerves. The present
study aims to investigate the density, arrangement, and structural features of
sympathetic nociceptive axons and terminals in whole-mount atrial tissues.
Calcitonin gene-related peptide (CGRP) and substance P are both peptidergic
neurotransmitters in capsaicin-sensitive sensory nerves (Holzer, 1991; Maggi, 1995;
Holzer and Maggi, 1998). The dorsal root ganglia contain both CGRP and SP sensory
neurons which project centrally to the dorsal horn in the spinal cord for pain sensation,
and peripherally to the heart (atria and ventricles) and other organs to detect the
chemical signals (e.g., bradykinin) that are released during injuries or through transient
receptor potential vanilloid (TRPV1)-mediated mechanism to induce neurogenic
responses (Zahner et al., 2003; Pan and Chen, 2004; Geppetti et al., 2008; Benemei et
1

al., 2009; Thornton et al., 2010). Since the sensation of the pain is first detected by
sympathetic (spinal) afferent terminals within the heart (Pan and Chen 2004), we
focused our study on peripheral sympathetic sensory axon fibers.
In the literature, the structure and function of CGRP-IR and SP-IR neurons and
axons have been examined in several different species (such as humans, dogs, cats,
guinea pigs, rats, mudpuppies; (Saito A et al., 1986; Parsons and Neel, 1987; Papka
and Urban, 1987; Shoba and Tay, 2000; Pan and Chen, 2002; Richardson et al., 2003;
Hoover et al., 2008, 2009; Mousa et al., 2010). However, most of these studies used
sectioned cardiac tissues in which axon and terminal structures have been largely
damaged, leading to fragmentary views of these axons and terminals in the heart.
Although whole-mount cardiac tissues were used in some studies, these studies mainly
focused on some special cardiac targets, such as cardiac ganglia, again leading to an
incomplete view of sympathetic afferent axons in the heart (Richardson et al., 2003;
Parsons et al., 2006). In addition, all these studies were in animal models that are
relatively larger than mice. No studies on CGRP-IR and SP-IR cardiac axons and
terminals were found in mouse models. In the past, mice have proven to be a favorable
model for the study of cardiac function and remodeling in disease states. One of the
values of the mouse model is the speed and ease with which it can be genetically
manipulated and bred to produce sustainable experimental populations. The size and
tissue characteristics of the mouse heart make it amenable to whole-mount studies of
cardiac nerve distribution which will allow for a more comprehensive, holistic (3-D)
characterization of these fibers, thus providing more information than previous studies
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of sectioned cardiac tissues in other species. CGRP and SP were chosen as
representative markers of nociceptive nerve types because they are highly specific to
nociceptive nerves, and their peptidergic nature makes them good targets for antibody
probes. Therefore, the goal of the present study is to study the innervation, distribution,
and morphology of the sympathetic afferent (CGRP and SP) axons and terminals in the
whole-mount atria of mice.
Previously, Cheng and his colleagues studied parasympathetic afferent and
efferent axons and terminals in the atria and aortic arch in normal and disease models
(aging, sleep apnea and diabetes) (Cheng et al. 1997a,b; 2004; Cheng and Powley
2000; Ai et al. 2007, 2009; Lin et al. 2008; Li et al. 2010). Recently, Cheng’s group has
studied sympathetic efferent innervation in normal mice (Harden et al. 2009; 2010). The
present study will document the distribution, and morphology of the sympathetic afferent
(CGRP and SP) axons and terminals in whole-mount atria of mice (Figure 3).
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MATERIALS AND METHODS
Animals
FVB mice (n=20, age 3 - 6 months) were used. All animals were housed in a
room in which light/dark cycles were set to 12 h/12 h (6:00 AM to 6:00 PM light cycle)
and provided food and water ad libitum. All procedures were approved by the
University of Central Florida Animal Care and Use Committee and strictly followed the
guidelines established by NIH. All experiments conformed to the University of Central
Florida guidelines on the ethical use of animals.
Tissue Preparation
Mice were anesthetized with a lethal dose injection of sodium pentobarbital (i.p.,
100 μg/g). Absence of hind paw pinch withdrawal reflex was used as an indicator to
ensure sufficient depth of anesthesia. Mice were perfused through the left ventricle with
40º C PBS (1 M phosphate-buffered saline, pH=7.4) for 5 minutes. The inferior venacava was cut to drain the blood for the perfusion. Tissues were then fixed by perfusion
with 4º C Zamboni’s fixative (15% picric acid and 2% paraformaldehyde in PBS,
pH=7.4). The heart and lungs were removed (Figure 2A) together with the trachea and
the esophagus to ensure the completeness of the cardiac tissues which were postfixed
in 4º C Zamboni’s fixative for 8-24 hours.
After postfixation, the heart and lungs were dissected apart. Briefly, the
pulmonary veins were separated from the lungs with fine tweezers and the lungs and
trachea were discarded (Figure 2B). Atria were separated from the ventricles with fine
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scissors along the atrial-ventricular groove (Figure 2C), and the aortic arch (AA) was
then separated from the atria (Figure 2D). The right and left atria were then separated
along interatrial septum. The dissected specimens are as follows (Figure 2E): right
atrium with the inferior vena cava (IVC), superior vena cava (SVC), and left precaval
vein (LPCV) attached, left atrium with pulmonary veins (PVs) attached and aortic arch
(Cheng et al. 1997; Ai et al. 2008).
Immunohistochemistry
All immunohistochemical procedures were performed on a shaker at room
temperature (75oF) in a 24 well plate (free floating method). Dissected tissues were
washed 6 x 5 minutes (6 times, 5 minutes each) in 0.01 M PBS pH=7.4 to remove the
remaining fixative. Tissues were then blocked 5 days in a blocking mixture containing
2% bovine serum albumin, 10% normal donkey serum, 0.08% Triton X-100, 0.08%
NaNH3 in 0.01 M PBS, pH=7.4, followed by a 24 hour primary antibody incubation
(CGRP, 1:1000; Substance P, 1: 500) (Table 1) in the solution (2% bovine serum
albumin, 4% normal donkey serum, 0.08% Triton X-100, 0.05% NaNH3 in 0.01 M PBS,
pH=7.4). The tissues were thoroughly washed 6 x 5 minutes in PBST (0.4% Triton X100 in 0.01 M PBS) to remove unbound primary antibodies. Tissues were then kept in
dark room and incubated in a secondary antibody solution (1:500 secondary antibody in
PBST) (Table 1) for 2 hours. 6 x 5 min washes in PBS were then used to remove
unbound secondary antibodies. Negative controls without primary antibodies were
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performed. Negative controls presented no immunoreactivity, confirming that
nonspecific binding of secondary antibodies did not occur.
Tissues were then mounted with their cranial surface up onto positively-charged
glass slides, crushed with lead weights for 1 hour, and air-dried under a fume hood for 1
hour. Slides were dehydrated by immersion for 2 minutes in each of 4 ascending
concentrations of ethanol (75%, 95%, 100% and 100%), followed by 2x10 min
immersions in 100% xylene. Slides were then coverslipped with DEPEX mounting
medium (Electron Microscopy Sciences #13514) and allowed to dry overnight. Tissues
were never allowed to dry except during the air drying step.
Data collection and analysis
Slides were examined using a Leica SP5 laser scanning confocal microscope
(objective: 20X oil) with HeNe laser (543 nm) for CGRP-IR axons and HeNe laser
(633nm) for SP-IR axons to show the overall innervation of CGRP-IR and SP-IR axons
in the whole-mount atria. The argon-krypton laser (488nm) was used to detect the
autofluorescence of the tissues (e.g., cardiac muscles and ganglionic cells) in the
background. The confocal projection images for assembling the montage of the atria
and the aortic arch which were scanned using a 20x oil immersion objective lens (zoom
X1). To show detailed CGRP-IR and SP-IR axon distribution in the heart, confocal
optical sectioned images were scanned using a 40x oil immersion objective lens (zoom
X2).
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All confocal images were scanned with the similar settings. Modifications,
including brightness and contrast adjustments, cropping and scale bar additions were
conducted utilizing Photoshop or NIH ImageJ (Collins, 2007) software.
Confocal montages were assembled using the landmark-based method for
efficient, robust, and automated computational synthesis of high-resolution, wide-area
images of a specimen from a series of overlapping partial views (Becker et al, 1996).
Individual scans of a small window with a certain size were first obtained and saved in
stacks of optical sectioned images. Then, these stacks were maximally-projected to
yield a series of all-in-focus maximum projection tiles. MosaicJ (Thévenaz and Unser,
2007) was utilized to assist in the assembly of these tiles to create large montage
images. Artifacts (air bubbles trapped in the mounting media) were manually removed
from the resulting images, but primarily outside of the perimeter of the tissue, and never
in the regions selected for representative image presentation.
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RESULTS
Innervation, distribution and morphology of CGRP-IR axon and terminals in wholemount atria
The whole-mount nature of atrial preparations allowed for the assessment of
CGRP-IR axon innervation in the right and left atria of a representative mouse (Figure 3
and 4, respectively). Although the distribution of CGRP-IR fibers was complex and
some variations in structural details were observed across animals, the general scheme
of CGRP-IR nerve distribution patterns were similar in all animals studied. This is shown
in the schematic drawing of this representative animal (Figure 5). In both right and left
atria (Figures 3, 4, and 5), large bundles of CGRP-IR axons, likely from the dorsal root
ganglia near the spinal cord, (see discussion) entered the atria. The large bundles
bifurcated multiple times into fine individual axons which formed extensive terminal endnets and free endings over the entire atria including the auricles and the entrance areas
of several major veins (Figures 6 and 8). The terminal end-nets were mostly in the
epicedium, where the fine axons were intermingled with the cardiac muscles in the
myocardium (Figure 7).
As reported before (Ai et al. 2007; Lin et al. 2008), a total of 15-20 intrinsic
cardiac ganglia of different sizes were found in the dorsal surface of the right and left
atria (Figure 5). CGRP fibers traveled in the connectives of these ganglia (Figure 9).
Some of CGRP-IR axons formed dense varicose endings around individual PNs in
ICGs, whereas others appeared passing by the ICGs (Figures 9 and 10). CGRP
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immunoreactivity was observed in numerous nerve fibers but was not found within the
somata of cardiac principle neurons (PNs) in our tissue. It appeared that innervation,
distribution and morphology of CGRP-IR axons in different areas of the right and left
atria followed a similar pattern.
CGRP-IR innervation of the whole-mount aortic arch
CGRP-IR axons were distributed along the wall of the aortic arch. Similar to the
atria, large CGRP-IR axon bundles bifurcated multiple times into single axons and
formed terminal end-nets and free terminals on the surface of the aortic arch (Figure
11).
Innervation, distribution and morphology of SP-IR axon and terminals in whole-mount
atria
Similar to CGRP-IR axon and terminals in the different regions of the left and
right atria, we found that several large SP-IR axon bundles entered the atria and
bifurcated into smaller bundles (Figure 12). Axons, terminal end-nets and free endings
were seen in all regions (e.g., Figure 12D and12E). In addition, varicose endings around
PNs were also seen (Figure 12F). Compared to CGRP-IR axon and terminals, we found
that there were much less SP-IR axons and terminals. Therefore, we did not present the
montage of the whole atria to show the overall innervation and distribution of SP-IR
axons and terminals.
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CGRP-IR and SP-IR innervation: dual labeling in the atria
Most SP-IR fibers also demonstrated CGRP immunoreactivity (Figure 13). Within
cardiac ganglia, the majority of SP-IR varicose terminals in ICGs were also
immunoreactive for CGRP (Figure 14), whereas some CGRP-IR varicose terminals
(green) did not exhibit colocalization of SP immunoreactivity. In the other areas of the
atria including the auricles and the entrance area of the major veins, we also found
colocalization of SP and CGRP in axons and terminals (not shown).
Since there were significantly more CGRP-IR axons and terminals than SP-IR
axons and terminals, we examined whether the effectiveness or sensitivity of the SP
antibody in labeling the axons was comparable to the CGRP antibody. We used
immunohistochemistry to label CGRP-IR and SP-IR axon fibers and terminals in the
small intestine. We found that CGRP and SP antibodies both strongly labeled axons
and detailed terminal structures in the small intestine (Figure 15). CGRP-IR axons
innervated the myentric ganglionic plexus and formed extensive varicose endings
around individual neurons with few free endings in the circular muscle, if any (Figure
15A and 15D). SP-IR axons terminated in the myentric ganglionic plexus and formed
extensive varicose endings around individual neurons as well as extensive networks in
the circular muscle layer (Figure 15E). Interestingly, SP-IR axons and terminals barely
colocalized with CGRP-IR axons and terminals (Figure 15C).
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DISCUSSION
In this study, we have for the first time characterized the distribution and
morphology of CGRP-IR and SP-IR axons and terminals in different areas over the
whole-mount atria of the FVB mouse model. These CGRP-IR and SP-IR axons
presumably originated from the dorsal root ganglia (DRG) (see below discussion), thus
they are sympathetic afferent axons. The detailed documentation of the arrangement
and structural details of sympathetic afferent axons and terminals in the whole-mount
atria may provide a foundation for the future study of pathological remodeling of cardiac
sympathetic afferent axons and terminals in diseases models.
Origin of CGRP-IR and SP-IR axons.
The extrinsic origin of cardiac CGRP-IR and SP-IR axons in the atria is an issue
that has not yet been resolved. In our study, we have examined all cardiac ganglia. We
found 15-20 cardiac ganglia of different sizes on the dorsal surface of the both right and
left atria. The cardiac ganglionic principal neurons (PNs) in these ganglia were neither
CGRP-IR nor SP-IR, indicating that cardiac CGRP-IR and SP-IR axons were not
intrinsic (i.e., from these cardiac ganglia) and thus must be extrinsic (i.e., from DRG or
Nodose ganglia). Since both DRG and the nodose ganglia may contain CGRP-IR and
SP-IR cardiac sensory neurons in dogs (Hoover et al. 2008), we had assumed that both
DRG and the nodose ganglia might have contributed to the CGRP-IR and SP-IR axons
and terminals in the mouse atrial tissue. In rats, we previously found that one of the
major terminal structures of vagal afferent axons from the nodose ganglion are the
11

terminal flower-sprays in the atria (Cheng et al. 1997), which has been confirmed in our
recent study of vagal afferent projections to the aortic arch (Li et al. 2010) and atria in
mice (unpublished). Therefore, we believe that the CGRP-IR and SP-IR cardiac axons
are most likely from the DRG, rather than from the nodose ganglia. This is further
supported by Hoover et al (2008) who injected the tracer HRP to the heart to label
cardiac sensory neurons in the DRG and nodose ganglia, and then stained for CGRPIR and SP-IR neurons. They found that HRP-labeled DRG neurons were 21% CGRPIR, 13% SP-IR, and 6% CGRP/SP-IR. In contrast, HRP-labeled neurons in nodose
ganglia were neither CGRP-IR nor SP-IR.
Innervation, distribution and morphology of CGRP-IR and SP-IR axons and terminals
in the whole-mount atria of mice.
In sliced preparations, previous studies demonstrated the CGRP-IR and SP-IR
axon innervate the atria in different species (Saito A et al., 1986; Parsons and Neel,
1987; Papka and Urban, 1987; Shoba and Tay, 2000; Pan and Chen, 2002; Richardson
et al., 2003; Hoover et al., 2008, 2009; Mousa et al., 2010). Since tissue cutting may
damage the 3-D structures of the axons and terminals, these studies could not show the
complete distribution and morphology of the axons and terminals over the entire atrium.
Although some studies labeled CGRP-IR and SP-IR axons and terminals in the wholemount cardiac tissue, the focus was mainly on innervation of cardiac ganglia
(Richardson et al., 2003; Parsons et al., 2006). In contrast to these studies, our study
presents a holistic view of CGRP-IR and SP-IR axon distribution, as well as
12

differentiated terminal structures at different regions of the whole right and left atria
(including auricles, the entrance areas of the major veins and cardiac ganglia). In
addition, our work demonstrated that CGRP-IR and SP-IR are colocalized in the
terminals within cardiac ganglia and formed pericellular endings around PNs as well as
varicose axons coursing through cardiac ganglia, whereas R. J. Richardson et al. only
found CGRP-IR and SP-IR varicose axons which did not form pericellular endings
around cardiac PNs in rats. Our study shows for the first time the complete innervation,
distribution, and morphology of sympathetic (spinal) afferent axons and terminals in the
mouse atria. No comparable studies have been found.
Functional implications
The sympathetic afferent neurons in the DRG are unipolar neurons. The central
limb of cardiac sympathetic afferent axons ends in the dorsal horn of the spinal cord and
the peripheral limb projects to the heart. Many studies have demonstrated that CGRP
and SP are localized in the axons and terminals centrally and peripherally (Willis and
Coggeshall, 1991; Seybold, 2009). Centrally, CGRP-IR and SP-IR terminals innervate
the neurons in the dorsal horn to transduce pain sensations. Peripherally, CGRP-IR and
SP-IR terminals are nociceptive sensory receptors. In our study, we examined
peripheral sympathetic afferent innervation in the atria. We found that CGRP and SP-IR
axons and terminals are in the epicardium, myocardium and intrinsic cardiac ganglia.
One important issue is why the sensory nerve terminals (which are supposed to be
sensory receptors) contain CGRP and SP, which are both neurotransmitters. This is
13

unusual because neurotransmitters should be in the presynaptic vesicles of motor axon
terminals, and not in sensory nerve terminals. In cardiac ganglia, physiological and
pharmacological studies have demonstrated that application of SP directly to cardiac
ganglionic cells may depolarize the membrane potentials, thus enhancing
parasympathetic efferent control of cardiac ganglia (Hoover et al., 2000; Figure 16). As
to whether CGRP may have any direct effects on cardiac ganglionic neurons is still an
issue (which is the question mark in Figure 16). Anatomically, there are many CGRP-IR
axons and terminals around cardiac ganglionic neurons (PNs) as shown in our present
study. However, the evidence for the direct physiological effect of CGRP on PNs is still
absent. Several groups applied CGRP to cardiac ganglia and made intracellular
recordings of the activity of PNs in an attempt to examine the effect of CGRP on PNs
physiologic properties, but they failed to find any positive effects (personal
communications). Since our anatomical data clearly demonstrated that CGRP-IR axons
formed many synaptic varicose contacts with PNs, we postulate that such a connection
of CGRP-IR axons with PNs may have functional implications which should be
examined in the future. In our preparation, we found many more CRGP-IR than SP-IR
axons and terminal in atrial muscles. Consistent with such a finding, Hoover et al.
observed abundant CGRP receptors but less SP receptors in atrial muscles (Hoover
and Hancock, 1988; Chang et al., 2001). Presumably, CGRP and SP may regulate
heart rate, AV conduction and cardiac contractility (Hoover et al., 2000; review). In the
entrance area of major veins to the atria, we found CGRP-IR and SP-IR axons and
terminals, which is consistent with the finding that CGRP and SP may have a
14

vasodilatory effect. Recently, it has been shown that CGRP and SP are released by
activation of TRPV1 receptors during cardiac ischemia, which increases preconditioning
and plays an important protective role during cardiac ischemia (Bolli and Abdel-Latif,
2005; Wang and Wang, 2005; Li et al., 2008; Zhong and Wang, 2008).
Technical considerations.
In this study, we found that there were many more CGRP-IR axons and terminals
than SP –IR axons and terminals. One concern was whether our immunostaining
protocol was sensitive enough to label SP-IR axons and terminals in the atria. To test
whether our protocol could effectively label the SP-IR axons and terminals, we used the
small intestine as a control. The SP antibody could effectively label SP-IR axons and
terminal networks in the circular muscle layer and pericellular endings around myenteric
ganglionic neurons in the small intestine. We also labeled CGRP-IR axons and
terminals in the small intestine. Compared to CGRP-IR axons and terminals, there are
many more SP-IR axons and terminals than CGRP-IR axons and terminals in the
circular muscles. This implies that our protocol can effectively label SP-IR axons and
terminals in the muscular layer. Therefore, we believe that there are indeed more
CGRP-IR axons and terminals than SP-IR axons and terminals in the atrial muscles.
In this study, we only performed CGRP and SP immunoreactivity in whole-mount
atria. Since the ventricle wall is much thicker than the atrial wall, it is questionable
whether our protocol may be directly applied to the ventricles due to potential
penetration problems. In the future, we need to improve our methods for ventricular
15

dissection, immunohistochemistry, and/or adopt our approach to use direct injection of
fluorescent tracers into the DRG to label sympathetic afferent axons and terminals in
the ventricles.
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PERSPECTIVES
In this study, we have presented a detailed documentation of the innervation,
distribution and morphology of CGRP-IR and SP-IR axons in the whole-mount atria of
mice. It has been shown that diseases (such as aging, sleep apnea, diabetes, and
cardiac failure) may remodel the autonomic nervous system. Previously, we examined
the effects of aging, intermittent hypoxia and diabetes on the vagal afferent and efferent
innervation of the atria and aortic arch (Ai et al. 2007; Lin et al. 2008; Li et al. 2010).
Schmidt et al. (2008) examined the aging and diabetes-induced changes of sympathetic
postganglionic neurons and efferent axons. Presumably, these diseases may also
damage the sympathetic afferent nerves as well. Previously, it has been assumed that
sensory nerve degeneration may lead to silent cardiac ischemia in diabetic patients
(Faerman et al., 1977; Gutterman, 2009). Recently, studies have shown that diabetes
may reduce TRPV1, CGRP, and SP mRNA expression which may impair the postischemic recovery in the hearts of diabetic mice (Song et al 2009; Wei et al. 2009). Our
study has provided a foundation for the future qualitative and quantitative analysis of the
pathological changes of sympathetic cardiac afferent axons and terminals in mouse
models, which may shed the light on the neural mechanisms for painless cardiac
ischemia as well as for the reduced beneficial effects of preconditioning against
ischemia/reperfusion-induced heart injury.
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APPENDIX: TABLES AND FIGURES
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Table 1: Antibodies Used
Antibody

Concentration

Host

Company

Emission

Anti-CGRP†

1 μl/ml

Goat

Abcam

n/a

Anti-SP†

2 μl/ml

Rabbit

Immunostar

n/a

Anti-Goat††

24 μl/ml

Donkey

Invitrogen

594 nm

Anti-Rabbit††

24 μl/ml

Donkey

Invitrogen

660 nm*

†primary
††secondary
*infrared fluorophores are invisible to human eyes
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Dr. Jack Cheng’s lab
17 papers published

?

Scott Harden
Two posters

Present study

Figure 1. Autonomic nervus system research progress review
A schematic drawing shows the summary of the research projects in Dr. Jack Cheng’s lab. 17 papers
related to the parasympathetic afferent and efferent pathways have been published. In addition, two
posters related to cardiac sympathetic efferent pathways have been presented in the international
scientific meetings (Scott et al. 2009; 2010). The focus of the present study is to examine the innervation,
distribution, and morphology of sympathetic (spinal) afferent axons and terminals in the atrium.
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Atria and
blood vessels

Auricles
Lungs
Ventricles

Ventricles

Ventricles

A

C

B
Right Atrium

Left Atrium

SVC

Auricle

Aortic arch
Auricle

D

E

IVC

PVs

LP-CV

Figure 2 Tissue preparation.
A. Heart and lungs were removed from a perfused and post-fixed FVB mouse.
B. Atrium and ventricles from the FVB mouse – esophagus, lungs and trachea were removed.
C. Atria were separated from the ventricles by cutting along the interatrial-ventricular groove.
D. The aortic arch was separated from the atria and pulmonary artery was removed.
E. Right and left atrium were separated by cutting along the interatrial septum.
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Right Atrium
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*

C
*

A
B

*

*
LP-CV

IVC
Figure.3 A montage of all-in-focus maximum confocal projections showing
CGRP-IR innervation and distribution in the right atrium of a FVB mouse.
A few large CGRP-IR axon bundles (indicated by solid arrows) entered the right atrium from SVC and L
P-C V. Then, they bifurcated into small bundles (indicated by open arrows) and single axons (indicated
by small arrows). Finally, these single axons covered all regions with terminal networks (see Figures 5
and 6 for detail) of the atrium, including the auricle and the entrance area of IVC, SVC and L P-C V. In
addition, CGRP-IR axons innervated multiple ICGs with varicose endings around individual cardiac
ganglionic principal neurons as indicated by * (see Figures. 5 and 7 for detail). Inferior vena cava: IVC;
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superior vena cava: SVC; left precaval vein: L P-C V. Intrinsic cardiac ganglion: ICG. Scale bar: 500 µm.
Note: Since this is a confocal montage which shows the overall distribution of CGRP-IR axons, the detail
structures of the axons and terminals are not visible in this image. The dotted frames A, B, and C are the
sampling windows where the detail structure of axon terminals will be presented in Figure 6.
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Figure 4. A montage of all-in-focus maximum confocal projections showing
CGRP-IR innervation and distribution of the left atrium of a FVB mouse.
A few large CGRP-IR axon bundles (indicated by solid arrows) entered the left atrium from left and right
PVs. Then, they bifurcated into small bundles (indicated by open arrows) and single axons (indicated by
small arrows). Finally, these single axons covered all regions with terminal networks (see Figures 5 and 6
for detail) of the atrium, including the auricle and the entrance area of PVs. In addition, CGRP-IR axons
innervated multiple ICGs with varicose endings around individual cardiac ganglionic principal neurons as
indicated by * (see Figures 5 and 7 for detail). Pulmonary veins: PVs. Scale bar: 500 µm. Note: Since this
is a confocal montage which shows the overall distribution of CGRP-IR axons, the detail structures of the
axons and terminals may not be visible in this image. The dotted frames A, B, and C are the sampling
windows where the detail structure of axon terminals will be presented in Figure 6.
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SVC

Auricle
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Auricle
PV

SA
AV
AV
PV

PV

LP-CV

IVC

PV

Right Atrium

Left Atrium

Figure 5. Two schematic drawings showing innervation and distribution of
CGRP-IR axons in the whole-mount right and left atria in the FVB mouse as
shown in Figures 3 and 4.
Each atrium was divided into an auricle region and the rest of the atrium including the entrance of the
large veins. The boundary is indicated by a dotted straight line. Large bundles of CGRP-IR axons (thick
lines) entered the atrium and then bifurcated into small bundles (thin lines) and ultimately the single axons
(dotted lines) with terminal networks and free endings (not shown at this magnification). Both atria
contained multiple intrinsic cardiac ganglia as indicated by blue blobs. SA, sino-atrial node region; AV
atrio-ventricular node region; inferior vena cava: IVC; superior vena cava: SVC; left precaval vein: L P-C
V; pulmonary veins: PVs. Scale bar: 500µm.
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Figure 6. CGRP-IR axons and terminals in the atria.
All-in-focus projections at the regions as indicated by A, B, C in the right and left atria in Figures 3 and 4.
Detail structures of CGRP-IR axons in different atria regions showed similar patterns. Multiple single axon
fibers formed terminal end-nets with free endings in epicardium and myocardium. White arrows:
branching points; yellow arrows: free endings. Scale bar: 50µm.
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M

M
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A

B

Figure 7. CGRP-IR axons in epicardium and myocardium.
A. A partial projection confocal image showing several axons (arrow) traveling in the epicardium (on the
surface of cardiac muscle). B. A single optical section showing that delicate CGRP axons (arrows) are in
myocardium and have close contacts with myocytes. M. cardiomyocytes. Scale bar: 50µm.
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LP-CV
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SVC

A

C

PV

B

D

Figure 8. CGRP-IR axons in the entrance area of the major veins.
All-in-focus projection images in: LP-CV (left precaval vein), SVC (superior vena cava), IVC (inferior vena
cava) of the right atrium; and PV (pulmonary vein) of the left atrium. Green color represents CGRP-IR
axons and red color represents autofluorescent background from atrial muscle layers (M). CGRP-IR
axons innervated the smooth muscles in atria exhibit the similar structure of terminal end-nets and free
endings as seen in the rest of the atria. Scale bar: 50 µm.
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Figure 9. CGRP-IR axons innervation of intrinsic cardiac ganglia (ICGs) in
the left atrium of a representative mouse.
A. Schematic drawing of the left atrium. In the dotted region, CGRP-IR axons (Green color) innervated
ICG neurons (Red color, autofluorescence). B. The dotted region in panel A at high magnification. C. A
partial projection of confocal optical sections from the ganglion (indicated by an arrow) in panel B showing
that CGRP-IR axon traveled in the connectives between ICGs. Some of these axons passed by the
ganglia, whereas others formed axonal varicosities around cardiac ganglionic principal neurons (PNs). D.
A High magnification of the boxed area in C showing such axonal varicosities around PNs. Noticeably,
none of PNs were CGRP-IR. Scale bar: 200 µm in panel A and panel B; 100 µm in panel C.; 10 µm in
panel D.
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C
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Figure 10. CGRP-IR axon innervation in the intrinsic cardiac ganglia (ICGs)
of the right atrium.
A. All-in-focus projection image at the AV region of the right atrium. A ganglion is identified within the
dotted frame. B. High magnification of the region with the dotted frame in panel A. C-D. Two different
optical sections showing that CGRP-IR varicosities wrapped around the individual PNs (arrows).
Triangles indicate CGRP-IR axons are passing by ICG PNs. Green: CGRP-IR; Red: autofluorescence.
Scale bars: 50 µm in panel A; 20 µm in panel B-D.

33

A

B

C

D

34

Figure 11. CGRP-IR axons in the aortic arch.
A. A schematic drawing of an aortic arch. B. All-in-focus projection confocal montage showing a large
CGRP-IR bundle (solid arrow) from the area enclosed by the dotted frame in panel A bifurcated (open
arrows) into single axons (small arrow) and formed complex terminal networks on the surface of the aortic
arch. C. All-in-focus projection confocal image showing the detail CGRP-IR terminals from the region
enclosed by the dotted frame in panel B. D. All-in-focus projection confocal image showing CGRP-IR
axons wrapped around the aortic arch. Green: CGRP-IR; Red: autofluorescence of the aortic arch. Scale
bar: 200 µm in panel B; 50 µm in panel C and panel D.
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Figure 12 SP-IR axons innervation in atria.
A. A SP-IR axon bundle in the right atrium. B. A SP-IR terminal end-net in the right atrium. C. A SP-IR
terminal end-net in the left atrium. D. SP-IR axons in the IVC. E. SP-IR axons in the PV. F. SP-IR axons
formed varicose endings around an ICG PN. Scale bars: A-E, 50µm; F, 20 µm.
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Figure 13 Colocalization of SP-IR axons
with CGRP-IR axons in an axon bundle.
A large axon bundle entered the right atrium and most
SP-IR (Red) fibers were found to have colocalized with
CGRP-IR (Green) fibers, indicating coexpression of
CGRP with SP (Yellow) in most SP-IR fibers.
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Figure 14. CGRP-IR and SP-IR Innervation of the ICGs: dual labeling.
A. Single confocal optic image shows CGRP-IR terminal varicosities. B. Single confocal optic image
shows SP-IR terminal varicosites. C. The merged image of panel A and panel B. PNs are in gray color.
Most of the SP-IR varicose terminals show colocalization of CGRP-IR in their terminal varicosities.
Colocalization of SP (Red) and CGRP (Green) in these terminals is signified by yellow in the composite
image (Red + Green) . Varicosities in pure green (CGRP-IR) color in panel C and panel F suggests that
although most SP-IR fibers show colocalized CGRP expression (Yellow), there are also many fibers
showing exclusive CGRP immunoreactivity (Green).
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Figure 15. CGRP-IR and SP-IR axons and terminals in the small intestine of
a FVB mouse.
A, B. Single confocal optic sectioned images show CGRP-IR (panel A), SP-IR (panel B) fibers and
terminals in the small intestine. C. Only a few varicosities show colocalized CGRP-IR and SP-IR as yellow
(trangle) in the composite images, whereas the majority do not. D E. All-in-focus projection confocal
images show CGRP-IR axons are mostly in the myenteric ganglia and only a few are in the muscle layer
(arrows), whereas many SP-IR axons are found richly both in circular muscles and myenteric ganglia .
Arrows: Free terminals. CM: Circular muscle. MG: Myenteric ganglia. Green: CGRP-IR; Red SP-IR;
Yellow; CGRP-IR + SP-IR.

40

Figure 16. Summary diagram of CGRP and SP innervation and functions in
the atria
CGRP-IR and SP-IR axons innervate ICGs, atrial myocytes and blood vessels. During insults (e.g.,
ischemia), CGRP-IR and SP-IR axon terminals are activated by endogenous chemicals (e.g. bradykinin)
which are released from the injured cardiac tissues and these pain signals are then sent to the central
nervous system (the spinal cord). In the meantime, CGRP-IR and SP-IR axon terminals may also have
“motor” functions, i.e., CGRP and SP may be released at these axon terminals locally to regulate the SA
heart rate, AV conduction, atrial muscle contractility, and vasodilation. These neuropeptides are either
released from the same axonal terminals or through the axon reflex mechanism (i.e., the chemical
simulation is at one site and the action is at another site nearby). ? indicates that the effects of CGRP-IR
axons on the target have not been completely elucidated. Similarly, ? indicates that the effects of SP-IR
axons on the target are not clear.
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